While no clear PIM-dependent changes in integrin activity or expression have previously been reported, we now found correlations between PIM1 or NFATC1 mRNA expression levels with ITGA5, both in PC-3 cells and in prostate cancer patient-derived samples. Here, NFATC1 is linked to prostate carcinoma.